Top Page
China BlueChemical
(OTC:3983)
China BlueChemical (3983) vs. S&P 500 (SPY)
China BlueChemical Business Overview & Revenue Model
China BlueChemical Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 11.95B | 12.99B | 14.28B | 13.40B | 10.42B | Gross Profit |
| 1.70B | 2.06B | 2.54B | 2.94B | 1.33B | EBIT |
| 1.06B | 1.42B | 1.82B | 2.23B | 689.68M | EBITDA |
| 1.55B | 3.33B | 2.35B | 2.76B | 1.32B | Net Income Common Stockholders |
| 1.07B | 2.38B | 1.64B | 1.50B | 745.49M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 13.51B | 13.74B | 13.03B | 11.46B | 10.17B | Total Assets |
| 24.08B | 24.32B | 23.50B | 21.43B | 20.75B | Total Debt |
| 2.12B | 2.02B | 2.08B | 1.05B | 1.98B | Net Debt |
| 1.44B | 1.42B | 1.55B | 371.11M | -787.71M | Total Liabilities |
| 4.57B | 4.91B | 5.72B | 4.52B | 5.12B | Stockholders Equity |
| 18.41B | 18.30B | 16.75B | 15.83B | 14.70B |
| Cash Flow | Free Cash Flow | |||
| 0.00 | 800.48M | 806.70M | 1.88B | 890.36M | Operating Cash Flow |
| 0.00 | 1.54B | 2.14B | 2.94B | 1.26B | Investing Cash Flow |
| 0.00 | -691.13M | -2.35B | -3.66B | 1.11B | Financing Cash Flow |
| 0.00 | -784.06M | 65.37M | -1.37B | -415.86M |
China BlueChemical Technical Analysis
China BlueChemical Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $793.48B | 10.00 | 12.78% | 8.12% | -7.73% | -6.97% | |
71 Outperform | $54.45B | 8.71 | 7.81% | 3.83% | 7.72% | 2.35% | |
65 Neutral | $8.99B | 7.74 | 5.83% | 10.36% | -9.71% | -56.34% | |
59 Neutral | HK$50.81B | 12.43 | 9.94% | 5.76% | 1.39% | -21.74% | |
49 Neutral | $1.97B | -1.18 | -21.24% | 3.71% | 1.29% | -31.16% |
China BlueChemical Corporate Events
China BlueChemical Ltd. has announced a final cash dividend of RMB 0.1208 per share for the financial year ending December 31, 2024. The announcement includes key dates for shareholders, such as the ex-dividend date on June 2, 2025, and the payment date on June 30, 2025. The company will withhold a 10% enterprise income tax for dividends distributed to non-resident enterprises. This announcement reflects the company’s commitment to returning value to its shareholders and may impact its financial positioning and attractiveness to investors.
China BlueChemical Ltd. has announced its upcoming annual general meeting scheduled for May 29, 2025, where several key resolutions will be considered. These include the approval of the board and supervisory committee reports, audited financial statements, profit distribution, and budget proposals for 2025. Additionally, the re-appointment of auditors and the appointment of new directors will be discussed. A special resolution will also be considered to grant the board a mandate to issue domestic and overseas shares, subject to regulatory approvals. This meeting is significant for stakeholders as it outlines the company’s strategic direction and governance for the upcoming year.
China BlueChemical Ltd. has announced a special resolution to be considered at its upcoming H Shareholders’ Class Meeting, which involves granting the board of directors a mandate to repurchase up to 10% of its overseas listed foreign shares, known as H Shares. This move is aimed at optimizing the company’s capital structure and potentially enhancing shareholder value, reflecting a strategic focus on market conditions and operational needs.
China BlueChemical Ltd. has announced a Domestic Shareholders’ Class Meeting to discuss and potentially approve a special resolution granting the board of directors the authority to repurchase up to 10% of its overseas listed foreign shares (H Shares). This move is aimed at aligning with market conditions and the company’s needs, potentially impacting its capital structure and shareholder value. The resolution will empower the board to manage the repurchase details, including pricing and timing, and make necessary amendments to the company’s articles of association to reflect any changes in registered capital.
China BlueChemical Ltd. has announced the closure of its register of members for H shares in preparation for its 2024 annual general meeting and class meetings scheduled for May 29, 2025. This move is aimed at determining the list of H shareholders eligible to attend and vote at these meetings, which are significant for the company’s governance and stakeholder engagement.
China BlueChemical, a joint stock limited company incorporated in China, has announced a series of transactions involving the subscription of structured deposit products with the Bank of China (BOC) Hainan Branch. The company has entered into multiple agreements, totaling RMB1,050 million, with the latest agreement being signed on March 27, 2025, for RMB150 million. These transactions are classified as discloseable under Hong Kong Listing Rules due to their aggregated transaction amounts exceeding certain percentage thresholds, necessitating notification and announcement requirements.
China BlueChemical Ltd. has announced a leadership change with the resignation of Mr. Hou Xiaofeng as Chief Executive Officer and President, effective March 18, 2025. Mr. Rao Shicai has been appointed to fill these roles, and there is a proposed appointment of Mr. Rao as an executive director and Mr. He Qizhong as a non-executive director, pending shareholder approval at the 2024 annual general meeting. This leadership transition may impact the company’s strategic direction and operations, as Mr. Rao brings extensive experience in engineering and management from his previous roles in the offshore oil industry.
China BlueChemical reported its annual financial results for the year ending December 31, 2024. The company achieved a revenue of RMB11,946 million and a gross profit of RMB1,705 million. Profit attributable to owners was RMB1,071 million, with basic earnings per share at RMB0.23. Despite a decrease in revenue and gross profit compared to the previous year, the company proposed a final dividend of RMB0.1208 per share, indicating a commitment to returning value to shareholders.
China BlueChemical Ltd. has announced a final cash dividend of RMB 0.1208 per share for the financial year ending December 31, 2024. The payment date is set for June 30, 2025, with specific details regarding the exchange rate, ex-dividend date, and record date yet to be announced. The company will withhold a 10% enterprise income tax on dividends distributed to non-resident enterprises. This announcement reflects the company’s financial health and commitment to returning value to its shareholders.
China BlueChemical Ltd. has announced a board meeting scheduled for March 17-18, 2025, to discuss and approve the annual results for the year ending December 31, 2024, and to consider a final dividend recommendation. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and potential returns, impacting its market positioning and shareholder value.
China BlueChemical Ltd. has issued a profit alert indicating a significant decrease in net profit for the year ending December 31, 2024, compared to the previous year. The expected decline is attributed to reduced production and sales of urea due to maintenance activities at three plants and a substantial drop in the prices of its main products. This announcement highlights potential challenges for the company and its stakeholders, as it navigates a period of decreased profitability.